Satoru Tanaka - Kao Executive

All Insiders . USA . 
Stock . Kao Corporation . Stakeholders . Insider . Satoru Tanaka
KAOCF Stock  USD 38.65  0.00  0.00%   

Executive

Satoru Tanaka is Executive Officer, Manager of Human Health-care Business Unit of Kao Corporation since 2018.
Tenure 6 years
Phone81 3 3660 7111
Webhttps://www.kao.com/jp/

Kao Management Efficiency

The company has return on total asset (ROA) of 0.0401 % which means that it generated a profit of $0.0401 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0886 %, meaning that it generated $0.0886 on every $100 dollars invested by stockholders. Kao's management efficiency ratios could be used to measure how well Kao manages its routine affairs as well as how well it operates its assets and liabilities.
Kao Corporation has accumulated 121.58 B in total debt with debt to equity ratio (D/E) of 0.26, which may suggest the company is not taking enough advantage from borrowing. Kao Corporation has a current ratio of 1.66, which is within standard range for the sector. Debt can assist Kao until it has trouble settling it off, either with new capital or with free cash flow. So, Kao's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kao Corporation sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kao to invest in growth at high rates of return. When we think about Kao's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Patrick MDHims Hers Health
66
Peter MDHims Hers Health
N/A
Alison LewisKimberly Clark
56
Dan DahlgrenThe Clorox
N/A
Seiichi MotoiUnicharm Corp
N/A
Toshifumi HikosakaUnicharm Corp
N/A
Rashida LandeEstee Lauder Companies
50
Ayesha ZafarCoty Inc
67
Olga LevinzonCoty Inc
N/A
Bradley HauserBeauty Health Co
47
Michael MonahanBeauty Health Co
52
Hirotatsu ShimadaUnicharm Corp
N/A
Khobi BrooklynHims Hers Health
N/A
Jonathan MayleHonest Company
33
Madhusudan GopalanProcter Gamble
46
Richard SlaterUnilever PLC ADR
46
Eric SchwartzThe Clorox
52
Susan WhaleyProcter Gamble
50
Valerie HaliburtonColgate Palmolive
N/A
Tadashi NakaiUnicharm Corp
61
Seth CohenProcter Gamble
N/A
Kao Corporation develops and sells cosmetic, skinhair care, human health care, fabric and home care, and chemical products. Kao Corporation was founded in 1887 and is headquartered in Tokyo, Japan. KAO CORP operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 33507 people. Kao Corporation [KAOCF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Equity0.0886
Return On Asset0.0401

Kao Corporation Leadership Team

Elected by the shareholders, the Kao's board of directors comprises two types of representatives: Kao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kao. The board's role is to monitor Kao's management team and ensure that shareholders' interests are well served. Kao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Atsushi Koizumi, Exec Management
Toshiaki Takeuchi, Executive Officer, Executive President of Subsidiary, Representative Director
Yoshihiro Hasebe, Executive Officer, Manager of Base Research Sector
Satoru Tanaka, Executive Officer, Manager of Human Health-care Business Unit
Tomoharu Matsuda, Executive Officer, Manager of Skin Care & Hair Care Business Unit
Hiroshi Yamaguchi, Sr limited
Hideki Mamiya, Executive Officer
Yasushi Wada, Executive Officer, Assistant Manager of Beauty Care SCM Center
Kenichi Yamauchi, Director of Administration in Accounting & Finance Division
Masakazu Negoro, Executive Officer, Manager of Chemical Business Unit, Chairman & President of Subsidiaries

Kao Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Kao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0886
Return On Asset0.0401
Profit Margin0.06 %
Operating Margin0.07 %
Current Valuation18.2 B
Shares Outstanding456.71 M
Shares Owned By Insiders2.67 %
Shares Owned By Institutions62.29 %
Price To Earning16.22 X
Price To Book2.55 X

Currently Active Assets on Macroaxis

TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft
HBIHanesbrands
STLDSteel Dynamics

Other Information on Investing in Kao Pink Sheet

Kao financial ratios help investors to determine whether Kao Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kao with respect to the benefits of owning Kao security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY